Search Results - "Benson, CA"

Refine Results
  1. 1

    Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice by Randle, Laura E, Goldring, Chris E.P, Benson, Craig A, Metcalfe, Peter N, Kitteringham, Neil R, Park, B. Kevin, Williams, Dominic P

    Published in Toxicology (Amsterdam) (20-01-2008)
    “…Abstract The Keap1-Nrf2-ARE signalling pathway has emerged as an important regulator of the mammalian defence system to enable detoxification and clearance of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co‐encapsulation by Browne, SH, Peloquin, C, Santillo, F, Haubrich, R, Muttera, L, Moser, K, Savage, GM, Benson, CA, Blaschke, TF

    Published in Clinical pharmacology and therapeutics (01-03-2018)
    “…High‐resolution measurement of medication adherence is essential to personalized drug therapy. A US Food and Drug Administration (FDA)‐cleared device, using an…”
    Get full text
    Journal Article
  4. 4

    "Nuclear FGF Receptor-1 and CREB Binding Protein: An Integrative Signaling Module" by Stachowiak, Michal K., Birkaya, B., Aletta, J.M., Narla, S.T., Benson, C.A., Decker, B., Stachowiak, E.K.

    Published in Journal of cellular physiology (01-05-2015)
    “…In this review we summarize the current understanding of a novel integrative function of Fibroblast Growth Factor Receptor‐1 (FGFR1) and its partner CREB…”
    Get full text
    Journal Article
  5. 5

    Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India by Jenks, J. D., Kumarasamy, N., Ezhilarasi, C., Poongulali, S., Ambrose, P., Yepthomi, T., Devaraj, C., Benson, C. A.

    “…SETTING: Y R Gaitonde Centre for AIDS Research and Education, Chennai, India.OBJECTIVE: To compare anti-tuberculosis treatment outcomes in individuals with…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    The use of pooled viral load testing to identify antiretroviral treatment failure by Smith, Davey M, May, Susanne J, Pérez-Santiago, Josué, Strain, Matthew C, Ignacio, Caroline C, Haubrich, Richard H, Richman, Douglas D, Benson, Constance A, Little, Susan J

    Published in AIDS (London) (23-10-2009)
    “…To develop less costly methods to virologically monitor patients receiving antiretroviral therapy, we evaluated methods that use pooled blood samples and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Pretreatment Factors Associated With 3-Year (144-Week) Virologic and Immunologic Responses to Potent Antiretroviral Therapy by Bosch, Ronald J, Bennett, Kara, Collier, Ann C, Zackin, Robert, Benson, Constance A

    “…OBJECTIVE:To examine pretreatment factors associated with longer term (144 weeks) responses to antiretroviral therapy (ART). METHODS:Of 1498 ART-naive subjects…”
    Get full text
    Journal Article
  13. 13

    Treating Opportunistic Infections among HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America by Benson, Constance A., Kaplan, Jonathan E., Masur, Henry, Pau, Alice, Holmes, King K.

    Published in Clinical infectious diseases (15-03-2005)
    “…The CDC, National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America have developed guidelines for treatment…”
    Get full text
    Journal Article
  14. 14

    Immunogenetics of CD4 Lymphocyte Count Recovery during Antiretroviral Therapy: An AIDS Clinical Trials Group Study by Haas, David W., Geraghty, Daniel E., Andersen, Janet, Mar, Jessica, Motsinger, Alison A., D’Aquila, Richard T., Unutmaz, Derya, Benson, Constance A., Ritchie, Marylyn D., Landay, Alan

    Published in The Journal of infectious diseases (15-10-2006)
    “…During antiretroviral therapy, CD4 lymphocyte count increases are modest in some patients despite virologic control. We explored whether polymorphisms in genes…”
    Get full text
    Journal Article
  15. 15

    Relationship Between CD4+ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials Study by SMURZYNSKI, Marlene, KUNLING WU, BENSON, Constance A, BOSCH, Ronald J, COLLIER, Ann C, KOLETAR, Susan L

    “…AIDS-defining events (ADEs) decreased in the era of highly active antiretroviral therapy but still lead to hospitalizations and deaths. Understanding factors…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Suppression of Cytomegalovirus Retinitis in Persons with AIDS with High-Dose Intravenous Acyclovir by Sha, Beverly E., Benson, Constance A., Deutsch, Thomas A., Urbanski, Pamela A., Phair, John P., Kessler, Harold A.

    Published in The Journal of infectious diseases (01-10-1991)
    “…To evaluate the efficacy and safety of high-dose intravenous acyclovir combined with oral zidovudine as suppressive therapy for cytomegalovirus retinitis in…”
    Get full text
    Journal Article
  18. 18

    Long-term increase in CD4 super(+) T-cell counts during combination antiretroviral therapy for HIV-1 infection by Lok, J J, Bosch, R J, Benson, CA, Collier, A C, Robbins, G K, Shafer, R W, Hughes, MD

    Published in AIDS (London) (01-01-2010)
    “…Objective: To inform guidelines concerning when to initiate combination antiretroviral therapy (ART), we investigated whether CD4 super(+) T-cell counts (CD4…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Prevalence and factors associated with dry skin in HIV infection : the FRAM study by LEE, Daniel, BENSON, Constance A, LEWIS, Cora E, GRUNFELD, Carl, SCHERZER, Rebecca

    Published in AIDS (London) (01-10-2007)
    “…Complaints of dry skin in HIV-infected individuals were reported after the advent of HAART. The objective of the study was to evaluate the prevalence of dry…”
    Get full text
    Journal Article